On Monday, Intrexon Corp (NYSE:XON)’s shares declined -7.35% to $40.86.
Intrexon Corp (XON) declared it has accomplished the acquisition of Okanagan Specialty Fruits (OSF), the pioneering agricultural company behind the Arctic® apple, the world’s first non-browning apple without the use of any flavor-altering chemical or antioxidant additives. OSF’s vision and ground-breaking effort in responsibly harnessing the power of technology to produce wholesome, nutritious food that is more appetizing and convenient to consumers is aligned with Intrexon’s strategy in the Food sector.
The combination of the talented OSF team under the continued leadership of Neal Carter, OSF Founder and President, and Intrexon’s technology platform opens the door to novel, designer foods that support the evolving healthy diet choices of consumer.
Intrexon Corporation, a biotechnology company, operates in the synthetic biology field in the United States. The company, through a suite of proprietary and complementary technologies, designs, builds, and regulates gene programs, which are DNA sequences that comprise of key genetic components.
Support.com, Inc. (NASDAQ:SPRT)’s shares dropped -7.14% to $1.69.
Support.com, Inc. (SPRT) declared full availability of SupportCam, a powerful remote video support service accessible within Nexus.
SupportCam addresses a major need in technical support: allowing the tech support representative to see exactly what a caller is looking at using the camera on the customer’s Apple(R) or Android(TM) smartphone or tablet. SupportCam works on any contact center agent’s computer running Mac OS(R) or Microsoft(R) Windows(R). It runs on Internet Explorer(R), Firefox(R), Chrome(R) and Safari(R) web browsers.
Support.com, Inc. provides cloud-based software and services in North America. It offers Nexus, a cloud based software-as-a-service solution that provides automation and analytics for companies to resolve technology issues and optimize support interactions with their customers.
At the end of Monday’s trade, Cytori Therapeutics Inc (NASDAQ:CYTX)‘s shares dipped -7.11% to $0.915.
Cytori Therapeutics Inc (CYTX) presented data from two preclinical studies funded through its contract with the United States Biomedical Advanced Research and Development Authority (BARDA) at the 2015 American Burn Association Meeting this week in Chicago. The findings provide greater detail as to how Cytori’s cellular therapeutic improves healing following thermal burn injury even in subjects with substantial radiation exposure.
Cytori Therapeutics, Inc., a biotechnology company, develops cell therapeutics for specific diseases and medical conditions. The company primarily provides Cytori Cell Therapy compriseing of a heterogeneous population of specialized cells, counting stem cells for the treatment of patients with scleroderma hand dysfunction, orthopedic disorders, cardiovascular disease, urinary incontinence, and thermal burns combined with radiation injury.
China Cord Blood Corp (NYSE:CO), ended its Monday’s trading session with -7.06% loss, and closed at $6.71.
China Cord Blood Corp (NYSE:CO) declared that its board of directors has received a non-binding proposal letter from Golden Meditech Holdings Limited (“Golden Meditech”), following which Golden Meditech proposes to acquire all of the outstanding ordinary shares of the Company not already directly or indirectly owned by Golden Meditech for US$6.40 per ordinary share in cash.
According to the proposal letter, which is dated April 27, 2015, the projected transaction is intended to be financed with a combination of accessible cash resources of Golden Meditech and debt and equity capital. In connection with the projected transaction, Golden Meditech also intends to acquire all of the 7% senior convertible notes of the Company following the terms and conditions of such convertible notes. A copy of the proposal letter is attached to this press release.
China Cord Blood Corporation, together with its auxiliaries, primarily provides umbilical cord blood storage and ancillary services in the People’s Republic of China.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
